DRLAX | MGLCX | DRLAX / MGLCX | |
Total Expense Ratio | 1.30 | 1.94 | 67% |
Annual Report Gross Expense Ratio | 1.77 | 1.95 | 91% |
Fund Existence | 19 years | 11 years | - |
Gain YTD | 6.683 | 3.043 | 220% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 304M | 2.22B | 14% |
Annual Yield % from dividends | 2.31 | 1.29 | 179% |
Returns for 1 year | 9.95 | 1.39 | 715% |
Returns for 3 years | 4.34 | -6.36 | -68% |
Returns for 5 years | 24.66 | 9.38 | 263% |
Returns for 10 years | 15.64 | 9.12 | 171% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SMVZX | 12.65 | 0.09 | +0.72% |
Virtus Ceredex Mid-Cap Value Equity R6 | |||
GPGEX | 8.69 | 0.01 | +0.12% |
Grandeur Peak Global Explorer Instl | |||
DBIWX | 10.86 | N/A | N/A |
DWS Global Macro R6 | |||
PIREX | 29.06 | -0.06 | -0.21% |
Principal Real Estate Securities Inst | |||
MSEPX | 23.18 | -0.09 | -0.39% |
Morgan Stanley Inst Emerging Mkts C |